Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25226400 | 0.92 | TSHR (0.39) | TSHRSTING1HDAC6HDAC1HDAC2 | |
| SCHEMBL3630266 | 0.89 | ALDH1A1 (0.50) | TSHRSTING1HDAC6HDAC1HDAC2 | |
| SCHEMBL2904495 | 0.89 | TSHR (0.65) | TSHRSTING1DGAT1CYP2D6CA2 | |
| SCHEMBL631111 | 0.89 | EGLN1 (0.48) | TSHRSTING1HDAC6HDAC1HDAC2 | |
| SCHEMBL15634991 | 0.89 | ADRA2A (0.39) | TSHRSTING1HDAC6HDAC1HDAC2 | |
| SCHEMBL6447333 | 0.89 | STING1 (0.38) | TSHRSTING1HDAC6HDAC1HDAC2 | |
| SCHEMBL1639757 | 0.88 | TSHR (0.50) | TSHRSTING1HDAC6HDAC1HDAC2 | |
| SCHEMBL134923 | 0.88 | EPHX2 (0.46) | TSHRSTING1HDAC6HDAC1HDAC2 | |
| SCHEMBL1926081 | 0.87 | STING1 (0.37) | TSHRSTING1HDAC6HDAC1HDAC2 | |
| Chloromethane SCHEMBL3415691 | 0.87 | EGLN1 (0.46) | TSHRSTING1HDAC6HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873407-B2 | Diketopyrrolopyrrole pigment compound having high weathering resistance and preparation method therof | CINIC CHEMICALS (SHANGHAI) CO., LTD. (CN) | 2024-01-16 | — | — | US | claimed |
| CN-116199995-A | High-fluidity polypropylene resin composition and molded article made from the same | 韩华道达尔能源有限公司 | 2023-06-02 | — | — | CN | claimed |
| CN-113121496-A | Method for preparing bioactive (S) - (-) -nicotine | 刘双红 | 2021-07-16 | — | — | CN | claimed |
| US-20210179855-A1 | DIKETOPYRROLOPYRROLE PIGMENT COMPOUND HAVING HIGH WEATHERING RESISTANCE, PREPARATION METHOD THERFOR, AND USE THEROF | CINIC CHEMICALS (SHANGHAI) CO., LTD. (CN) | 2021-06-17 | — | — | US | claimed |
| EP-3733783-A1 | DIKETOPYRROLOPYRROLE PIGMENT COMPOUND HAVING HIGH WEATHER RESISTANCE, PREPARATION METHOD THEREFOR AND USE THEREOF | Cinic Chemicals Shanghai Co. Ltd. (CN) | 2020-11-04 | — | — | EP | claimed |
| CN-102822152-A | Novel 1,3-oxazolidine compounds and their use as renin inhibitors | NOVADEX PHARMACEUTICALS AB | 2012-12-12 | — | — | CN | claimed |
| US-5914426-A | Process for the preparation of di-tert-butyl succinate | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-06-22 | — | — | US | claimed |
| CN-1196350-A | Process for preparation of di-tert-butyl succinate | CIBA GEIGY AG (CH) | 1998-10-21 | — | — | CN | claimed |
| JP-10324663-A | — | — | None | — | — | JP | disclosed |
| US-20260146129-A1 | BIO-BASED SUCCINIC ACID COMPOSITION, PREPARATION METHOD THEREFOR, AND POLYESTER PREPARED THEREFROM | SHANGHAI KINGFA SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2026-05-28 | — | — | US | disclosed |
| US-20260146267-A1 | BIO-BASED SUCCINIC ACID COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF | Zhuhai Kingfa Biomaterial Co., Ltd. (CN) | 2026-05-28 | — | — | US | disclosed |
| US-20260146126-A1 | SUCCINIC ACID COMPOSITION, POLYESTER PREPARED THEREFROM, AND POLYESTER COMPOSITE MATERIAL | Zhuhai Kingfa Biomaterial Co., Ltd. (CN) | 2026-05-28 | — | — | US | disclosed |
| EP-4748822-A2 | BIO-BASED SUCCINIC ACID COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF | Zhuhai Kingfa Biomaterial Co., Ltd. (CN) | 2026-05-27 | — | — | EP | disclosed |
| EP-4748823-A1 | BIO-BASED SUCCINIC ACID COMPOSITION, PREPARATION METHOD THEREFOR, AND POLYESTER PREPARED THEREFROM | Shanghai Kingfa Science & Technology Co., Ltd (CN) | 2026-05-27 | — | — | EP | disclosed |
| EP-0163442-A1 | Process for the preparation of esters of dicarboxylic acids | The British Petroleum Company p.l.c. (GB) | 1985-12-04 | — | — | EP | disclosed |
| US-4414153-A | 1,3-Dithietane-2-carboxylic acid penicillin and cephalosporin derivatives | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1983-11-08 | — | — | US | disclosed |
| US-4404373-A | Process for the preparation of 7α-methoxy-7β-(1,3-diethietane-2-carboxamido)cephalosporanic acid derivatives | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1983-09-13 | — | — | US | disclosed |
| US-4263432-A | ANTIBIOTICS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1981-04-21 | — | — | US | disclosed |
| US-4198339-A | INTERMEDIATES FOR PENICILLINS AND CEPHALOSPORINS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1980-04-15 | — | — | US | disclosed |
| US-4085274-A | OXIDIZING CYCLODODECEN-1-YLPROPIONIC ACID DERIVATIVE | DAICEL LTD. (JA) | 1978-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146267-A1 | BIO-BASED SUCCINIC ACID COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF | SUCLA2, SUCLG2, LDHA | TSHR 4522/4885STING1 3756/4885HDAC6 4052/4885 |
| US-20260146126-A1 | SUCCINIC ACID COMPOSITION, POLYESTER PREPARED THEREFROM, AND POLYESTER COMPOSITE MATERIAL | MTOR, RICTOR, SQSTM1 | TSHR 4879/4885STING1 2705/4885HDAC6 3293/4885 |
| US-20260146129-A1 | BIO-BASED SUCCINIC ACID COMPOSITION, PREPARATION METHOD THEREFOR, AND POLYESTER PREPARED THEREFROM | SUCLA2, SUCNR1, SUCLG2 | TSHR 4802/4885STING1 4160/4885HDAC6 4026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.